When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

Pamela Arway Biography and Net Worth

Director of DaVita

Ms. Arway served in a number of capacities during her 21-year career with the American Express Company, Inc. until her retirement in 2008. Ms. Arway served as president, Japan/Asia Pacific/Australia Region, American Express International, Inc., Singapore from October 2005 to January 2008. From December 2004 to October 2005, Ms. Arway served as chief executive officer, American Express Australia Ltd., Sydney, Australia. From July 2000 to December 2004, Ms. Arway served as executive vice president and general manager, Corporate Travel North America, American Express Company, Inc.

Ms. Arway has been a director of Iron Mountain since 2014, a director of The Hershey Company since 2010, and a director of DaVita Healthcare Partners, Inc. since 2009. Ms. Arway holds a Bachelor’s degree in languages from Memorial University of Newfoundland and a Master of Business Administration degree from Queen’s University, Kingston, Ontario, Canada.

What is Pamela M. Arway's net worth?: The estimated net worth of Pamela M. Arway is at least $2.07 million as of October 9th, 2023. Ms. Arway owns 15,562 shares of DaVita stock worth more than $2,066,167 as of April 26th. This net worth estimate does not reflect any other assets that Ms. Arway may own. Learn More about Pamela M. Arway's net worth.
How do I contact Pamela M. Arway?: The corporate mailing address for Ms. Arway and other DaVita executives is 2000 16TH STREET, DENVER CO, 80202. DaVita can also be reached via phone at (720) 631-2100 and via email at [email protected]. Learn More on Pamela M. Arway's contact information.
Has Pamela M. Arway been buying or selling shares of DaVita?: Pamela M. Arway has not been actively trading shares of DaVita in the last ninety days. Most recently, Pamela M. Arway sold 446 shares of the business's stock in a transaction on Tuesday, November 23rd. The shares were sold at an average price of $102.86, for a transaction totalling $45,875.56. Learn More on Pamela M. Arway's trading history.
Who are DaVita's active insiders?: DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.
Are insiders buying or selling shares of DaVita?: In the last year, insiders at the sold shares 9 times. They sold a total of 181,836 shares worth more than $21,270,343.49. The most recent insider tranaction occured on February, 26th when CEO Javier Rodriguez sold 67,603 shares worth more than $8,525,414.33. Insiders at DaVita own 1.4% of the company. Learn More about insider trades at DaVita.
Information on this page was last updated on 2/26/2024.

Pamela M. Arway Insider Trading History at DaVita

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/23/2021	Sell	446	$102.86	$45,875.56
8/23/2021	Sell	365	$133.09	$48,577.85	19,239
5/24/2021	Sell	379	$123.12	$46,662.48	19,239
3/22/2021	Sell	436	$109.51	$47,746.36	19,239
11/20/2020	Sell	430	$107.88	$46,388.40	19,239
8/24/2020	Sell	578	$87.02	$50,297.56	19,239
5/22/2020	Sell	599	$78.90	$47,261.10	19,239
3/20/2020	Sell	625	$71.25	$44,531.25	19,239
6/7/2018	Sell	1,264	$68.76	$86,912.64	39,235
5/25/2016	Sell	10,824	$77.16	$835,179.84	36,394
2/29/2016	Sell	9,026	$66.00	$595,716.00	36,070

Pamela M. Arway Buying and Selling Activity at DaVita

DaVita Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Today's Range

Now: $132.77

$131.34

$133.18

50 Day Range

MA: $131.89

$120.89

$139.24

2 Week Range

Now: $132.77

$71.51

$141.54

Volume

519,286 shs

Average Volume

802,587 shs

Market Capitalization

$11.64 billion

P/E Ratio

17.94

Dividend Yield

N/A

Beta

1.04

The Gold Grab of the Century

From Colonial Metals | Ad